J
JW Therapeutics is an innovative biotech company focusing on the latest clinical cell therapy technology. It is commited to the development, transformation and promotion of breakthrough cell-based immunotherapies to save the lives of cancer patients, improve their quality of life and bring new hope. JW Therapeutics was co-founded by WuXi AppTec, Juno Therapeutics in February 2016.
Investor insights
Funding rounds participated in
$100M sweet spot round size
Investor type
Self-Owned
Basic info
Industry
Biotechnology
Sectors
Biotechnology
Date founded
2016
Funding rounds raised
Total raised
$100M
from 3 investors over 1 rounds
J
JW Therapeutics 药明巨诺 raised $100M on July 11, 2020
Investors: Mirae Asset, CPE and + 8 Other investors